Emphasizing Branded Medications Klinic remains dedicated to using exclusively FDA-approved branded medications for diabetes and weight management
No significant heterogeneity among studies ( I 2 = 33%, p =0.18), so the fixed-effects model was used to combine the effect sizes
Yes, many patients without diabetes qualify for GLP-1 therapy based on BMI, insulin resistance, cardiovascular risk, or metabolic syndrome
Journal of Thoracic and Cardiovascular Surgery 161(3):760-771.e2, 2021
These natural strategies are safer, sustainable and proven to enhance the same anabolic pathways that synthetic peptides target, without legal or long-term health concerns
Tidball JG, Wehling-Henricks M: Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events